Related Experiment Video
Updated: May 8, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
Fusarium, Scedosporium and Other Rare Mold Invasive Infections: Over Twenty-Five-Year Experience of a European
Marie-Pierre Ledoux1, Elise Dicop2, Marcela Sabou3,4
1Department of Hematology, Institut de Cancérologie de Strasbourg, 67033 Strasbourg, France.
Abstract:
Invasive mold infections (IMD) are an emerging concern due to the growing prevalence of patients at risk, encompassing but not limited to allogeneic hematopoietic stem cell transplant recipients, hematological malignancies patients, solid organ transplant recipients and intensive care unit patients. In contrast with invasive aspergillosis and mucormycosis, other hyalohyphomycoses and phaeohyphomycoses remain poorly known. We conducted a retrospective analysis of the clinical, biological, microbiological and evolutive features of 92 IMD having occurred in patients in our tertiary-care center over more than 25 years. A quarter of these infections were due to multiple molds. Molds involved were Fusarium spp. (36.2% of IMD with a single agent, 43.5% of IMD with multiple agents), followed by Scedosporium spp. (respectively 14.5% and 26.1%) and Alternaria spp. (respectively 13.0% and 8.7%). Mortality at day 84 was higher for Fusarium spp., Scedosporium spp. or multiple pathogens IMD compared with Alternaria or other pathogens (51.7% vs. 17.6%, p < 0.05). Mortality at day 84 was also influenced by host factor: higher among hematology and alloHSCT patients than in other patients (30.6% vs. 20.9% at day 42 and 50.0% vs. 27.9% at day 84, p = 0.041). Better awareness, understanding and treatments are awaited to improve patient prognosis.
Insights
Invasive mold infections (IMD) are a growing concern, with Fusarium and Scedosporium species causing higher mortality. Understanding these less-known fungal infections is crucial for improving outcomes in at-risk patients.
Area of Science:
- Mycology
- Infectious Diseases
- Clinical Microbiology
Background:
- Invasive mold infections (IMD) are increasing due to a rise in immunocompromised patient populations.
- Hyalohyphomycoses and phaeohyphomycoses are less understood compared to invasive aspergillosis and mucormycosis.
- Patients at risk include stem cell transplant recipients, those with hematological malignancies, solid organ transplant recipients, and ICU patients.
Purpose of the Study:
- To retrospectively analyze the clinical, biological, microbiological, and evolutive features of 92 invasive mold infections.
- To identify common and emerging mold pathogens causing IMD.
- To assess mortality rates and influencing factors in IMD patients.
Main Methods:
- Retrospective analysis of 92 cases of invasive mold infections over 25 years.
- Microbiological identification of causative mold species.
- Clinical data collection including patient demographics, risk factors, and outcomes.
- Statistical analysis of mortality rates and associated factors.
Main Results:
- A quarter of IMD cases involved multiple fungal pathogens.
- Fusarium spp. (36.2%) and Scedosporium spp. (14.5%) were the most common single-agent pathogens.
- Mortality at day 84 was significantly higher for Fusarium spp., Scedosporium spp., or multiple-pathogen IMD (51.7%) compared to other pathogens (17.6%).
- Mortality was also higher in hematology and allogeneic hematopoietic stem cell transplant (alloHSCT) patients.
Conclusions:
- Fusarium and Scedosporium species, along with polymicrobial infections, are associated with increased mortality in IMD.
- Hematological malignancy and alloHSCT patients face a higher risk of mortality from IMD.
- Enhanced awareness, understanding, and treatment strategies are needed to improve prognoses for invasive mold infections.
More Related Videos
Related Concept Videos
Fungal Group Zygomycota
Fungal Phylum Microsporidia
Fungal Phylum Ascomycota
Fungal Phylum Basidiomycota

